BRINCIDOFOVIR | N214460 | EMERGENT BIODEFENSE OPERATIONS LANSING LLC
| Patent # | Expiration | PED | Drug Substance | Drug Product | Use Code | Delist |
|---|---|---|---|---|---|---|
| 9303051 | Jul 30, 2034 | — | Yes | Yes | — |
| Code | Date | Status |
|---|---|---|
| ODE-354 | Jun 4, 2028 | Active |
Emergent BioDefense listed patent 9,303,051 for Tembexa (brincidofovir) in the Orange Book with a revised expiration date of Jul 2034, extended from Aug 2031.
Old: Aug 31, 2031
New: Jul 30, 2034